| 货号 | 中文名称 | 英文名称 | CAS |
| WT-IS-B01853 | Beta-Carotene (>) (12,12',13,13',14,14',15,15',20,20'-13C10 99%) | Beta-Carotene (>) (12,12',13,13',14,14',15,15',20,20'-13C10 99%) | 301150-50-5;Unlabeled:7235-40-7 |
| WT-IS-B00601 | Beta-Carotene (10,10',11,11'-13C4 99%) | Beta-Carotene (10,10',11,11'-13C4 99%) | 146563-29-3;Unlabeled:7235-40-7 |
| WT-IS-B02166 | Beta-Carotene (10,10',19,19,19,19',19',19'-d8 97%) | Beta-Carotene (10,10',19,19,19,19',19',19'-d8 97%) | 53163-44-3;Unlabeled:7235-40-7 |
| WT-IS-B03423 | Buspirone:HCI (Butyl-d8 98%) | Buspirone:HCI (Butyl-d8 98%) | Unlabeled:33386-08-2 |
| WT-IS-B03420 | Caffeine (1,3-15N2 99%) | Caffeine (1,3-15N2 99%) | Unlabeled:58-08-2 |
| WT-IS-B00444 | Caffeine (2-13C 99%; 1,3-15N2 98%+) | Caffeine (2-13C 99%; 1,3-15N2 98%+) | 135252-57-2;Unlabeled:58-08-2 |
| WT-IS-B00868 | Chloral Hydrate (Trichloromethyl-13C 97%) | Chloral Hydrate (Trichloromethyl-13C 97%) | 201612-49-9;Unlabeled:302-17-0 |
| WT-IS-B00922 | Choline Chloride (1,2-13C2 99%) | Choline Chloride (1,2-13C2 99%) | 202190-49-6;Unlabeled:67-48-1 |
| WT-IS-B02257 | Choline Chloride (Trimethyl-d9 98%) | Choline Chloride (Trimethyl-d9 98%) | 61037-86-3;Unlabeled:67-48-1 |
| WT-IS-B02256 | Choline Chloride (Trimethyl-d9 98%) Microbiological/Pyrogen Tested | Choline Chloride (Trimethyl-d9 98%) Microbiological/Pyrogen Tested | 61037-86-3;Unlabeled:67-48-1 |
| WT-IS-B03411 | Cis-(+/-)-Tramadol:HCI (Methoxy-13C 99%) | Cis-(+/-)-Tramadol:HCI (Methoxy-13C 99%) | Unlabeled:36282-47-0 |
| WT-IS-B00182 | Cis-Urocanic Acid (1,2,3-13C3 99%) | Cis-Urocanic Acid (1,2,3-13C3 99%) | 1173097-34-1;Unlabeled:7699-35-6 |
| WT-IS-B02344 | Clonidine (4,4,5,5-Imidazoline-d4 98%)100 ug/ml in Methanol | Clonidine (4,4,5,5-Imidazoline-d4 98%)100 ug/ml in Methanol | 67151-02-4;Unlabeled:4205-90-7 |
| WT-IS-B02343 | Clonidine:HCI (4,4,5,5-Imidazoline-d4 98%) | Clonidine:HCI (4,4,5,5-Imidazoline-d4 98%) | 67151-02-4;Unlabeled:4205-91-8 |
| WT-IS-B01060 | Clozapine (4-Methylpiperazinyl-d4 97%) | Clozapine (4-Methylpiperazinyl-d4 97%) | 204395-52-8;Unlabeled:5786-21-0 |
| WT-IS-B03422 | Creatine (15N3 98%) | Creatine (15N3 98%) | Unlabeled:57-00-1 |
| WT-IS-B03414 | Creatine (Guanidino-13C 99%) | Creatine (Guanidino-13C 99%) | Unlabeled:57-00-1 |
| WT-IS-B00561 | Creatine (Methyl-d3 98%) | Creatine (Methyl-d3 98%) | 143827-19-4;Unlabeled:57-00-1 |
| WT-IS-B00560 | Creatine (Methyl-d3 98%) Microbiological/Pyrogen Tested | Creatine (Methyl-d3 98%) Microbiological/Pyrogen Tested | 143827-19-4;Unlabeled:57-00-1 |
| WT-IS-B03405 | Creatine Monohydrate (Methyl-13C 99%) | Creatine Monohydrate (Methyl-13C 99%) | Unlabeled:6020-87-7 |
| WT-IS-B00175 | Desethylamodiaquine (Ethyl-d5 97%) | Desethylamodiaquine (Ethyl-d5 97%) | 1173023-19-2;Unlabeled:79352-78-6 |
| WT-IS-B01585 | Dexamethasone (4,6-Alpha,21,21-d4 96%) (May Contain D At C-2) | Dexamethasone (4,6-Alpha,21,21-d4 96%) (May Contain D At C-2) | 2483831-63-4;Unlabeled:50-02-2 |
| WT-IS-B02924 | Diazepam (Phenyl-d5 98%) | Diazepam (Phenyl-d5 98%) | N/A;Unlabeled:439-14-5 |
| WT-BE-B10733 | DL-2-Hydroxyglutaric Acid Disodium Salt | DL-2-Hydroxyglutaric Acid Disodium Salt | 40951-21-1 |
| WT-IS-B01301 | DL-2-Hydroxyglutaric Acid Disodium Salt (13C5 99%) | DL-2-Hydroxyglutaric Acid Disodium Salt (13C5 99%) | 2482467-23-0;Unlabeled:40951-21-1 |
| WT-IS-B02374 | DL-Nicotine (Methyl-d3 98%) | DL-Nicotine (Methyl-d3 98%) | 69980-24-1;Unlabeled:22083-74-5 |
| WT-IS-B02330 | DL-Nornicotine (Pyridine-d4 98%) | DL-Nornicotine (Pyridine-d4 98%) | 66148-18-3;Unlabeled:5746-86-1 |
| WT-IS-B00314 | DL-Secobarbital (1-Methyl-d3,Butyl-2,2-d2,98%) | DL-Secobarbital (1-Methyl-d3,Butyl-2,2-d2,98%) | 1219803-94-7;Unlabeled:76-73-3 |
| WT-IS-B01005 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (1,1,2,2-d4 97-98%) | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (1,1,2,2-d4 97-98%) | 203633-19-6;Unlabeled:62-31-7 |
| WT-IS-B01901 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (1-13C 99%) | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (1-13C 99%) | 335081-04-4;Unlabeled:62-31-7 |
| WT-IS-B02001 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (1-13C 99%; 15N 99%) | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (1-13C 99%; 15N 99%) | 369656-74-6;Unlabeled:62-31-7 |
| WT-IS-B01770 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (2,2-d2 97-98%) | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (2,2-d2 97-98%) | 27160-01-6;Unlabeled:62-31-7 |
| WT-IS-B03417 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (2-13C 99%) | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (2-13C 99%) | Unlabeled:62-31-7 |
| WT-IS-B01899 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (Ring-13C6 99%) | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (Ring-13C6 99%) | 335080-94-9;Unlabeled:62-31-7 |
| WT-IS-B01168 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (Ring-d3 95%; 2,2-d2 95%) | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (Ring-d3 95%; 2,2-d2 95%) | 2193106-55-5;Unlabeled:62-31-7 |
| WT-IS-B02174 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (Ring-d3 98%) | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI) (Ring-d3 98%) | 53587-30-7;Unlabeled:62-31-7 |
| WT-IS-B02923 | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI)(1,1-d2 93%) 96-98% Pure | Dopamine:HCI (2-(3,4-Dihydroxyphenyl)- Ethylamine:HCI)(1,1-d2 93%) 96-98% Pure | N/A;Unlabeled:62-31-7 |
